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Human cytomegalovirus (HCMV) systematically manages the expression of cellular functions, rather than
exerting the global shutoff of host cell protein synthesis commonly observed with other herpesviruses during
the lytic cycle. While microarray technology has provided remarkable insights into viral control of the cellular
transcriptome, HCMV is known to encode multiple mechanisms for posttranscriptional and posttranslation
regulation of cellular gene expression. High-throughput Western blotting (BD Biosciences Powerblot technol-
ogy) with 1,009 characterized antibodies was therefore used to analyze and compare the effects of infection with
attenuated high-passage strain AD169 and virulent low-passage strain Toledo at 72 hpi across gels run in
triplicate for each sample. Six hundred ninety-four proteins gave a positive signal in the screen, of which 68
from strain AD169 and 71 from strain Toledo were defined as being either positively or negatively regulated by
infection with the highest level of confidence (BD parameters). In follow-up analyses, a subset of proteins was
selected on the basis of the magnitude of the observed effect or their potential to contribute to defense against
immune recognition. In analyses performed at 24, 72, and 144 hpi, connexin 43 was efficiently downregulated
during HCMV infection, implying a breakdown of intercellular communication. Mitosis-associated protein
Eg-5 was found to be differentially upregulated in the AD169 and Toledo strains of HCMV. Focal adhesions
link the actin cytoskeleton to the extracellular matrix and have key roles in initiating signaling pathways and
substrate adhesion and regulating cell migration. HCMV suppressed expression of the focal-adhesion-asso-
ciated proteins Hic-5, paxillin, and -actinin. Focal adhesions were clearly disrupted in HCMV-infected
fibroblasts, with their associated intracellular and extracellular proteins being dispersed. Powerblot shows
potential for rapid screening of the cellular proteome during HCMV infection.
Human cytomegalovirus (HCMV) is a clinically important
herpesvirus associated with severe disease following congenital
infection and in immunocompromised individuals. As a her-
pesvirus, primary infection is accompanied by lifelong persis-
tence during which the infection must be controlled by contin-
uous host immune surveillance. HCMV has the largest genome
of any characterized human virus (236 kb) and is predicted to
encode on the order of 165 potential open reading frames (15).
Systematic deletion of individual open reading frames from the
Towne strain revealed that only 45 are essential for virus rep-
lication in vitro; thus, accessory genes account for most of the
HCMV coding capacity (16). While the functions of most of
these genes have not been determined, a significant number
have been implicated in the targeting of both the innate and
adaptive host immune responses (40). HCMV has also recently
been shown to express microRNAs during productive infection
that also have the potential to modulate host cell gene expres-
sion (17, 21, 43). A high-throughput proteomic approach was
used in this study with a view to providing further insight into
how the virus may modulate its host cell.
HCMV replicates slowly in permissive human fibroblasts, with
gene expression conventionally being divided into three phases:
immediate-early (IE), early, and late (reviewed in reference 40).
Early-phase transcription precedes viral DNA replication (ini-
tiates at 16 to 24 h postinfection [hpi]), with significant virus
production detected from 72 hpi and peaking at approximately
144 hpi. Productive HCMV infection is associated with an overall
stimulation of both cellular transcription and translation (50).
Virion binding (13, 59), release of virion tegument proteins fol-
lowing virion fusion (6, 36), and de novo expression of powerful
transcriptional regulators (most notably, IE2 and IE1) during
infection all modulate cellular gene expression. Following infec-
tion, while cellular proteins associated with DNA metabolism are
induced, host cell cyclins are dysregulated and licensing of host
cell DNA replication is inhibited, resulting in a “pseudo-G1”
environment compatible with efficient virus DNA replication (3,
5, 25). Microarray experiments have proved highly informative in
revealing the dynamic regulation of steady-state levels of cellular
transcripts, both positively and negatively, during the course of
infection (7, 26, 48, 65, 66). HCMV is known not only to regulate
transcriptional initiation but also to control RNA processing (1, 9,
14, 20, 35, 63), translation, and posttranslational modification and
protein trafficking (31, 34, 44, 54, 61). The result of many of these
processes is liable to be an alteration of host cell protein levels.
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While HCMV strains AD169 and Towne are used exten-
sively in research, their genomes are recognized to have accu-
mulated genetic defects during extensive passage in vitro, the
most substantial being a deletion of a 13- to 15-kb sequence
designated UL/b (11, 15). Vaccine trials have indicated that
the genetic alterations accrued by the laboratory strains have
rendered them relatively avirulent, whereas a limited-passage
Toledo strain showed virulence characteristics in early pas-
sages (45). The characterized strain Toledo UL/b sequence
has at some stage undergone a sequence inversion that inac-
tivates UL128, a gene required for endothelial tropism. Re-
pairing the deletion in the Towne strain with the strain Toledo
UL/b sequence was not sufficient to restore virulence (24), yet
it did confer a much enhanced capacity to resist natural killer
cell (NK) recognition (54). The UL/b sequence has been pre-
dicted to encode 23 additional open reading frames, including
genes implicated in regulating viral tropism (UL128 to
UL131A) (15, 23) and immune modulation, including two che-
mokine homologues (UL146, UL147) (42, 49) and a tumor
necrosis factor receptor homologue (UL144) (2), and confers
remarkable protection against NK attack (10, 58) associated
with the NK evasion functions UL141 and UL142 (12, 54, 57,
62). In HCMV-infected cells, posttranslational control of cel-
lular ligands is a major factor in both promoting and evading
NK recognition. HCMV encodes at least four genes that act
posttranslationally to suppress cell surface major histocompat-
ibility complex class I expression, UL40 donates a peptide that
enables maturation of HLA-E, and gpUL16 binds to and pre-
vents maturation of NKG2D ligands, while gpUL141 binds to
nectin-like molecule 5 (Necl-5/CD155/PVR), preventing its
maturation (34, 53, 54, 61). In order to gain further insight into
the effect of HCMV infection on host defenses, we used Pow-
erblot (BD Biosciences) technology to evaluate the overall
effects of HCMV infection on the cellular proteome.
The Powerblot system uses an inventory of 1,009 monoclo-
nal antibodies to evaluate the relative levels of protein expres-
sion in a high-throughput immunoblotting assay. To allow time
for changes to be manifested, lysates were prepared from
strain AD169-infected, strain Toledo-infected, and mock-in-
fected fibroblasts at 72 hpi. Triplicate samples were analyzed
on separate polyacrylamide gels. Following immunoblotting,
positive signals were measured with an infrared capture system
and densitometry measurements were performed. Pairwise
comparisons adjusted by compensation with normalized con-
trols provided a quantitative readout that was further checked
by visual inspection. Powerblot technology was used to identify
cellular proteins whose expression is modulated positively and
negatively during productive infection. In follow-up studies to
validate the technology, we observed a clear effect on proteins
implicated in the regulation of intercellular interactions. In this
context, HCMV was observed to suppress the expression of
multiple cellular proteins involved in focal adhesion (-actinin,
paxillin, Hic-5) and connexin junctions (connexin 43).
MATERIALS AND METHODS
BD Powerblot. Human fetal foreskin fibroblasts (HFFF) were mock infected
or infected with HCMV strain Toledo or AD169 at a multiplicity of infection
(MOI) of 5. At 72 hpi, whole cells were lysed in boiling lysis buffer (10 mM Tris,
pH 7.4, 1 mM sodium orthovanadate, 1% sodium dodecyl sulfate [SDS]) con-
taining protease inhibitor cocktail (P8340; Sigma), sonicated, frozen at 80°C,
and sent to BD Biosciences on dry ice for analysis.
BD separated all of the samples on a 0.5-mm-thick 4 to 15% gradient SDS-
polyacrylamide gel. Samples equivalent to approximately 8 g per lane were
loaded, and the gel was run for 1.5 h at 150 V. Samples were transferred with a
wet-transfer TE series (Hoefer) to Immobilon-P membrane (Millipore) for 2 h at
200 mA. For antibody detection, the membrane was blocked for 1 h with blocking
buffer (LI-COR) and clamped with a Western blotting manifold that isolated 40
channels across the membrane. In each channel, a complex antibody cocktail was
added and allowed to hybridize for 1 h at 37°C. The blot was removed from the
manifold, washed, and hybridized for 30 min at 37°C with secondary goat anti-
mouse antibody conjugated to Alexa Fluor 680 fluorescent dye (Molecular
Probes) and goat anti-rabbit antibody conjugated to IRDye 800 fluorescent dye
(Rockland). The membrane was washed, dried, and scanned at 700 nm (for
monoclonal antibody target detection) and 800 nm (for polyclonal antibody
target detection) with the Odyssey infrared imaging system (LI-COR). Molecular
weight standards were loaded with two standardization cocktails.
BD performed densitometry analysis of the detected bands. These readings
were normalized to the sum intensity of all of the valid spots on a blot and then
multiplied by 1,000,000, and the molecular weight was determined. Analysis was
provided in the form of pairwise comparisons for each protein between each pair
of samples. This was performed between triplicate readings for each sample,
giving a three-by-three comparison matrix for each pair of proteins. These
comparisons were then ranked on the basis of the size of the change observed,
the reproducibility of that change between the triplicate repeats, and the abso-
lute strength or quality of the signal on the polyvinylidene difluoride membrane.
These analyses were performed both by computer analysis and by visual inspec-
tion of the membranes. In this manner, changes were ranked into 10 levels
(Table 1). For the Powerblot data obtained in this study, see Fig. SA to SD in the
supplemental material.
TABLE 1. Parameters used by BD to assign confidence levels to changes in protein expression
Level Description
10 ............................................Changes of greater than 2-fold in 9 of 9 comparisons from good-quality signals that pass visual inspectionc
9 ..............................................Changes of 1.5- to 1.9-fold in 9 of 9 comparisons from good-quality signals that pass visual inspectionc
8 ..............................................Changes of greater than 2-fold in 9 of 9 comparisons from low-quality signalsa that pass visual inspectionc
7 ..............................................Changes of 1.25- to 1.5-fold in 9 of 9 comparisons from good-quality signals
6 ..............................................Changes of greater than 2-fold in 9 of 9 comparisons from good-quality signals that do not pass visual inspectionc
5 ..............................................Changes of 1.5- to 1.9-fold in 9 of 9 comparisons from good-quality signals that do not pass visual inspectionc
4 ..............................................Changes of greater than 2-fold in 9 of 9 comparisons from low-quality signalsa that do not pass visual inspectionc
3 ..............................................Low-signal data,b changes of 1.5- to 1.9-fold in 9 of 9 comparisons
2 ..............................................Low-signal data,b changes of 1.25- to 1.49-fold in 9 of 9 comparisons
1a ............................................Changes of greater than 2-fold in 8 of 9 comparisons
1b ............................................Changes of 1.5- to 1.9-fold in 8 of 9 comparisons
a Low- versus high-quality signals are determined by analysis software and are not subject to technician judgment.
b Low-signal data are for signals with a normalized quantity of 500 or low quality. Results can be inconsistent.
c Visual inspection is done by a technician, and there are instances when a band (signal) is not visible to the human eye but is still discerned by the analysis software.
A greater confidence value is assigned when a visual inspection can confirm the software-based determination, so when the technician is unable to see the band a lower
confidence level is assigned to the signal.
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Cells and virus. HFFF were infected with HCMV for 2 h with rocking,
following which the cells were washed with phosphate-buffered saline (PBS) and
fresh medium was added. Virus strain Toledo (kindly provided by E. S. Mocar-
ski), AD169, or an AD169 mutant which expresses green fluorescent protein
(GFP) under the control of the -2.7 early promoter (AD169-GFP) (39) was
used. Virus stocks were prepared from HFFF infected with the required virus.
Tissue culture supernatants were kept when a 100% cytopathic effect (CPE) was
observed and were centrifuged to remove cell debris. Cell-free virus was pelleted
from supernatant by centrifugation at 22,000 	 g for 2 h and then resuspended
in fresh Dulbecco modified Eagle medium.
Western blotting. HFFF were mock infected or infected (MOI of 5) with
HCMV strain Towne or AD169, and samples were harvested exactly as for the
Powerblot but additional time points were taken (24, 72, and 144 hpi). Protein
concentration estimation was performed with the bicinchoninic acid protein
assay reagent (Pierce) according to the manufacturer’s instructions, and an 8-g
sample was run per lane. Samples were diluted in 2	 SDS loading buffer (250
mM Tris, pH 6.8, 2% [wt/vol] SDS, 10% [vol/vol] glycerol, 100 mM dithiothreitol,
0.1% [wt/vol] bromophenol blue), and SDS-polyacrylamide gel electrophoresis
was performed (46).
Gels were blotted onto polyvinylidene difluoride membrane (Amersham), and
prestained molecular weight standards (Rainbow Marker; Amersham) were used
to monitor protein transfer. Membranes were blocked for 1 h in blocking buffer
(5% dried milk, 0.1% Tween 20 in PBS) before being incubated for an hour in
primary antibody diluted in blocking buffer. Membranes were washed for 30 min
with three changes of washing buffer (0.1% Tween 20 in PBS), and incubated
with horseradish peroxidase-conjugated secondary antibody (1:1,000 dilution;
Amersham) for an hour. Another 30-min wash, with three changes of wash
buffer, was performed, and samples were reacted with SuperSignal reagent
(Pierce). Primary anti-Hic-5 (61164), anti-Eg5 (61186), anti-RIG-G (611244),
anti-paxillin (P49620), anti--actinin (612576), anti-FAK (610087), and anti-
connexin 43 (610061) monoclonal antibodies were obtained from BD Bio-
sciences and used at the recommended dilutions. Anti-CD29 (21270291S) and
anti-CD49e (21336491S) antibodies were obtained from Immunotools and used
at a 1:10 dilution.
Luminescence was detected with the Autochemi system (UVP), and densi-
tometry measurements were made with Labworks 4.5 software (UVP). All mea-
surements were taken from original images without any destructive image pro-
cessing, and all measurements for any single antibody were taken simultaneously.
Measurements from any single antibody are therefore comparable.
Immunofluorescence. With the exception of focal-adhesion-associated pro-
teins, all immunofluorescence analysis was performed at 48 hpi to minimize
binding to the Fc receptors expressed strongly by HCMV at later time points in
infection. Cells were fixed for 15 min in 2% paraformaldehyde, washed in PBS,
and then permeabilized in 0.5% NP-40 for 15 min. Cells were incubated with
primary antibody for 1 h at 37°C, washed, and incubated for 1 h at 37°C with
secondary antibody before being washed and mounted in 2% 1,4-
diazabicyclo[2.2.2]octane (DABCO). Primary antibodies were the same as for
Western blotting (see above) and were again used at the manufacturer-recom-
mended dilution. The secondary antibody was goat anti-mouse Alexa Fluor 594
conjugate (Molecular Probes) used at 1:5,000.
For imaging of focal-adhesion proteins, cells were grown on fibronectin-cov-
ered coverslips. Ten micrograms of fibronectin (Sigma) was added to the cover-
slips, and they were incubated overnight at 4°C. The coverslips were washed, and
the cells were allowed to adhere. Cells were grown in 2% fetal calf serum to
prevent overgrowth, infected as described above, and stained at 72 hpi. To
prevent reactions with Fc receptors, the secondary antibody was chicken anti-
mouse Alexa Fluor 594 conjugate (Molecular Probes) used at 1:1,000.
4,6-Diamidino-2-phenylindole (DAPI; Sigma) was added to the secondary
antibody at a final concentration of 1 g/ml. Images were viewed on a Leica
DM-IRBE microscope at a magnification of 	630 with a Hamamatsu
ORCA-ER camera and processed with Openlab 3 (Improvision).
RESULTS
Powerblot. In total, 1,009 antibodies were used in the Pow-
erblot to analyze expression from HFFF that were mock in-
fected or infected with strain AD169 or Toledo. HCMV infec-
tion is recognized to stimulate cellular metabolism while
simultaneously dysregulating normal cell cycle progression. In
contrast, control cells will continue to progress through the cell
cycle, divide, and eventually become growth inhibited when
reaching confluence. This situation needs always to be borne in
mind when comparing HCMV-infected cells with uninfected
controls. The mass of both uninfected and infected cells will
change over time. As infected cells are unable to divide, there
are fewer cells each with a higher protein content, relative to
mock-infected controls. Total-protein measurements of cell
extracts analyzed in the Powerblot showed that levels in in-
fected cells were 1.6 to 1.9 times those of mock-infected con-
trols (Table 2). Since the amount of protein applied in each
sample was constant, a protein whose expression remains un-
changed in absolute abundance in an infected cell will thus
decrease in relative abundance compared to that in an unin-
fected cell. However, such a decrease in “relative abundance”
may also have an impact on function. In this study, this issue
was circumvented by focusing on proteins that underwent a
greater-than-twofold change in abundance (i.e., confidence
levels 1a, 4, 8, and 10 as defined by BD parameters; Table 1) as
a consequence of infection. Lysed samples were run on SDS-
polyacrylamide gel electrophoresis in triplicate and Western
blotted before being probed with multiple antibody cocktails,
each containing five to eight antibodies which recognize pro-
teins of differing molecular masses. Following binding with a
secondary antibody, data were captured with an infrared cap-
ture system and densitometry measurements were performed
on the triplicate samples. Pairwise comparisons were per-
formed between every pair of samples, with changes expressed
as  or  and as an n-fold change compared to normalized
controls. Of the 1,009 antibodies, 837 were designated as re-
acting with human proteins and of these, 686 to 694 proteins of
the expected molecular mass were recognized in any one cel-
lular extract. A visual comparison is included within BD’s scor-
ing system (Table 1). Despite built-in compensation, disparity
in transfer or antibody-binding efficiency within some blots was
manifested as a variation between scores in the set of nine
pairwise comparisons for each individual protein (see Fig. SA
to SD in the supplemental material).
A total of 71 (Toledo-infected versus mock-infected cells),
68 (strain AD169-infected versus mock-infected cells), or 13
(strain Toledo-infected versus strain AD169-infected cells)
proteins changed with the highest confidence level (level 10)
(see Fig. SB to SD in the supplemental material). A compar-
ison identified a set of 37 proteins that changed with level 10
confidence in both the strain Toledo-versus-mock-infected cell
and strain AD169-versus-mock-infected cell comparisons. A
significant number of proteins clearly exhibited a confidence
level 10 change with only one of the viruses. When evaluated
individually, these proteins that were observed to change ( or
) substantially with one virus often also changed similarly
with the other strain, but with a confidence change lower than
level 10. In nearly all of the cases, this was due to variation
between the triplicate repeats in one of the comparisons pre-
TABLE 2. Protein concentrations of whole-cell lysates sent to
BD for Powerblot analysis
Samples Protein concn (mg/ml)
Mock-infected HFFF ............................................................0.299
Strain AD169-infected HFFF ..............................................0.466
Strain Toledo-infected HFFF ..............................................0.567
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venting an accurate and reliable n-fold change reading being
derived. Thus, while we focused in this study on proteins mod-
ulated with level 10 confidence, further examination of the
Powerblot data can be expected to identify more cellular pro-
teins differentially modulated by HCMV infection. Neverthe-
less, upon examining the level 10 proteins for all three com-
parisons, we found a bias for protein increases in the infected
cells compared to controls; 39 (57%) of 68 (strain AD169-
infected versus mock-infected cells) and 45 (63%) of 71 (To-
ledo-infected versus mock-infected cells) level 10 proteins
showed increases rather than decreases in the comparisons.
Validation of Powerblot data. A subset of nine proteins
shown to be modulated by HCMV infection in the Powerblot
experiment was selected for further analysis by conventional
Western blotting (Table 3). In the follow-up study, duplicate
mock-infected control samples were used and cell extracts
were collected at 24, 72, and 144 hpi. Care was taken to ensure
that the same amount of protein was loaded for each sample.
Total protein concentrations were determined in a standard
chemical assay (see Materials and Methods) and checked by
performing densitometric measurements on Coomassie blue-
stained SDS-polyacrylamide gel electrophoresis gels (data not
shown). For all of the proteins examined, the monoclonal an-
tibody was the same designation as that used in the Powerblot.
All nine of the proteins selected for follow-up exhibited level
10 significance changes between virus-infected and mock-in-
fected cells and provided strong signals in the Powerblot. How-
ever, no difference in expression level was observed between
virus- and mock-infected cells for three of the nine proteins
(FXR2, hPRP17, and ZAG) in a follow-up Western analysis
(Table 3). Proteins FXR2 and hPRP17 were not detected at
substantial levels in any sample in the follow-up Western anal-
ysis (data not shown), while for the Zn-2 glycoprotein (ZAG),
the signal was attributed to a breakdown product of a higher-
molecular-weight protein detected by a different antibody in
the Powerblot cocktail. For the remaining six proteins, good
concordance was seen between follow-up analysis and the Pow-
erblot. Four of these proteins were analyzed further because
their modulation indicated that HCMV infection may be hav-
ing a specific effect on focal adhesions and intercellular com-
munication; this selection thus allowed us to test the predictive
power of the Powerblot.
Connexin 43. Gap junctions form pores between cells which
are in direct contact and enable cell-to-cell communication via
the transmission of ions and other small molecules. Connexin
43 is one of a family of connexins (the only one found in
fibroblasts) which form these gap junctions when they self-
oligomerize into hexameric structures, surrounding a central
aqueous pore. Intracellular transport through a gap junction
potentially could be detrimental to HCMV if, for example, it
facilitated the transfer of interferons. The Powerblot indicated
that connexin 43 was efficiently downregulated by infection
with both HCMV strains (Fig. 1A). Follow-up analysis sup-
ported the Powerblot result. Indeed, connexin 43 downregula-
tion was apparent by 24 hpi, with levels dropping below de-
tectability at 144 hpi (Fig. 1A and B). Comparable levels
of downregulation were observed with strains AD169 and
Toledo.
Fibroblasts did not readily form gap junctions in in vitro
culture, even in confluent monolayers. Immunofluorescence
analysis shows that connexin 43 was predominantly associated
with characteristic intracellular structures in uninfected cells
that are thought to be associated with storage (H. Evans, per-
sonal communication). Figure 1C shows that by 48 hpi, not
only was the overall level of connexin 43 reduced but the
associated cytoplasmic structures became less prominent, to
the point that in some infected cells they were not detectable.
Eg5. Eg5 is a kinesin-related protein that regulates spindle
formation at the centrosome, ensuring appropriate distribution
of duplicated chromosomes between daughter cells (4). Eg5
was not detected by Powerblot in mock-infected cells, yet it was
expressed at high levels following HCMV infection. In the
conventional Western blot assay, Eg5 was detected at 24 h in
mock-infected cells but declined over time as cells became
confluent, in line with its recognized role in mitosis (18) (Fig.
2A and B). At 24 hpi, Eg5 was expressed at comparable levels
in the HCMV-infected and mock-infected cell extracts. While
Eg5 declined in control cells, it was sustained (strain Toledo)
or enhanced (strain AD169) as the infection progressed (Fig.
2A and B). This is best observed directly when the 24- and
144-h time points are compared directly (Fig. 2C).
In contrast to mock-infected cells, infection with HCMV
strain AD169 induced strong upregulation of Eg5 at both 72
and 144 hpi. The situation is more complex with strain Toledo,
where in contrast to the Powerblot, the upregulation of Eg5
was less than that observed with strain AD169 and represents
a difference that was consistent across experimental repeats
(data not shown) in the modulation of cellular gene expression
by these two HCMV strains that was not apparent in the
Powerblot.
TABLE 3. Proteins selected for follow-up analysis
Protein Comment HCMV-induced change accordingto Powerblot
Connexin 43 Enables intercellular communication Downregulation
Eg5 Regulates mitotic-spindle formation Upregulation
FXR2 Fragile X mental retardation autosomal homolog Upregulationa
Hic-5 Focal-adhesion-associated protein Downregulation
hILP/XIAP Inhibitor of apoptosis Upregulation
hPRP17 Splicing factor Upregulationa
Paxillin Focal-adhesion-associated protein Downregulation
RIG-G Retinoic-acid-induced gene G Upregulation
ZAG Zn-2-glycoprotein, related to class I major histocompatibility complex Downregulationa
a Not confirmed in follow-up.
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HCMV infection is associated with the accumulation of the
mitotic cyclin-dependent kinase (cdk) cdk1/cyclin B1 complex.
Furthermore, HCMV infection has been associated with the
induction of a “pseudomitotic” state that involves the forma-
tion of spindle poles and abnormal chromosome condensation
in a proportion of the cells. The sustained expression of Eg-5
may be related to aberrant activation of cell cyclins, whereas
cell division in control cells becomes constrained by confluence
inhibition, suppressing Eg-5 levels.
Eg5 levels are increased, even in nondividing neurons, at
points where changes in cellular architecture are occurring
(18). Immunofluorescence studies were therefore carried out
to examine Eg-5 localization in infected cells (Fig. 2D). A low
MOI was used to enable comparison with uninfected cells in
the same field. Enhanced levels of Eg5 staining were detected
in strain AD169-infected cells; however, there was no obvious
localization with specific intracellular structures. An identical
staining pattern was seen at a high MOI and at both low and
high MOIs with strain Toledo-infected cells (data not shown).
Paxillin. Focal adhesions are membrane nucleation sites
where actin filaments are linked to the extracellular matrix via an
integrin bridge. Paxillin is a cytoskeletal protein associated with
focal adhesions that is subjected to extensive tyrosine phosphory-
lation as a consequence of changes in cell adhesion and morphol-
ogy (56). Powerblot detected two major forms of paxillin that
differentially migrate with apparent molecular masses of 58 and
68 kDa. Of these, only the 58-kDa form changed significantly,
showing a sevenfold (strain AD169) or fivefold (strain Toledo)
reduction in expression levels at 72 h compared to mock-infected
cells (see Fig. SB and SC in the supplemental material; Fig. 3A).
The major 58-kDa form and the minor 68-kDa species were also
apparent in the follow-up conventional Western blot analysis, as
well as a 46-kDa form. Infection with strains AD169 and Toledo
caused fourfold and sevenfold reductions, respectively, at 72 hpi
compared to the mock-infected control if only the predominant
58-kDa species is considered, while the 46-kDa species was not
detectable in infected cells after 24 h. Mock-infected cells showed
a decrease in paxillin levels at 144 hpi such that strain AD169-
infected levels were comparable to those of mock-infected cells at
this time point. Paxillin levels were lower in strain Toledo-infected
cells than in strain AD169-infected cells; thus, levels were still
reduced, relative to those in mock-infected cells, at 144 h in strain
Toledo-infected cells.
Immunofluorescence analysis revealed a clear difference be-
tween cells infected with a strain AD169 virus and mock-
infected controls (Fig. 3C). Focal adhesions are more clearly
FIG. 1. Analysis of connexin 43 expression. (A) Densitometry measurements from conventional Western blot assays (MOI 
 5) are shown on
the left side of the graph, and those from the Powerblot (MOI 
 5) are on the right. (B) Conventional Western blot assays from which
measurements were taken (MOI 
 5). (C) Immunofluorescence assay performed on HFFF infected 48 h previously (MOI 
 0.5) with strain
AD169-GFP such that infected cells appear green. Cells were stained with DAPI to locate the nuclei of all of the cells (blue) and for connexin 43
(red).
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visualized when cells are plated at a low density on coverslips
coated with fibronectin. The structures staining for paxillin in
the uninfected cells are characteristic of focal adhesions and
were clearly not detectable following HCMV infection. Paxillin
became dispersed throughout the cell and exhibited a much
more homogeneous cytoplasmic distribution. Identical patterns of
disruption of focal adhesions were seen when infections were
performed at a low MOI and when strain Toledo-infected cells
were stained (data not shown).
Hic-5 (ARA-55). Hic-5 is known as an androgen and glu-
cocorticoid receptor coactivator (19, 64) and a negative regu-
lator of muscle differentiation (27). However, Hic-5 also local-
izes to focal adhesions, is subject to tyrosine phosphorylation,
and is similar to paxillin in its primary structure (22, 38, 51).
Hic-5 expression was downregulated by 20- to 28-fold following
infection with strains AD169 and Toledo in the Powerblot (Fig.
4A). The follow-up Western transfer experiment confirmed
that Hic-5 levels were much lower in infected cells than in
mock-infected cells. The difference in expression levels was
detectable by 24 hpi but much stronger at 72 hpi (7- to 10-fold)
and 144 hpi. Interestingly, comparing the different time points
indicated that Hic-5 was increasing in mock-infected cells, with
FIG. 2. Analysis of Eg5 expression. (A) Densitometry measurements of Eg5 from conventional Western blot assay data are on the left side of
the graph (MOI 
 5), and Powerblot data (MOI 
 5) are on the right. (B) Conventional Western blotting data from which measurements were
taken (MOI 
 5). (C) Eg5 levels from different time points on a single blot, allowing direct visual comparison of levels at 24 and 48 hpi.
(D) Immunofluorescence assay performed at 48 hpi (MOI 
 0.5) with a strain AD169 variant encoding GFP. Staining for Eg-5 is shown in red;
DAPI staining of nuclei is in blue.
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the reduction in infected cells possibly representing a failure to
accumulate rather than active degradation. While the predom-
inant 50-kDa protein and the minor 60-kDa species were both
lower during infection, a minor 68-kDa species was not sup-
pressed by HCMV infection. The Hic-5 protein associated with
structures typical of focal adhesion in uninfected cells, whereas
in infected cells the Hic-5 signal was weaker and was again
associated with a general cytoplasmic distribution (Fig. 4C).
The Hic-5 staining pattern was also consistent with a disrup-
tion of focal adhesions during infection. Experiments per-
formed at both a high MOI and with strain Toledo-infected
cells infected at both high and low MOIs showed identical
disruptions of focal adhesions in infected cells (data not
shown).
Other focal-adhesion proteins. Since HCMV infection in-
duced both the dispersal and downregulation of the key focal-
adhesion proteins paxillin and Hic-5, we hypothesized that
additional proteins associated with focal adhesions may also be
displaced. -Actinin is involved in the binding of the cytoplas-
mic domain of integrins with actin filaments. Powerblot re-
vealed that -actinin expression was suppressed in strain To-
ledo-infected cells (level 9 confidence) and that 1 integrin
(CD29) was downregulated in both strain AD169-infected and
strain Toledo-infected cells (level 10 confidence). We also in-
vestigated the intracellular localization of the major signal
transducer associated within the focal adhesions, focal-adhe-
sion kinase (FAK), and 5 integrin (CD49e) in uninfected and
strain AD169-infected cells (Fig. 5). A clear difference can be
seen between the infected and uninfected cells, with proteins
on the cytoplasmic face of the focal adhesions (-actinin),
proteins involved with signal transduction from the focal ad-
hesions (FAK), and the integrins which anchor the focal ad-
hesions to the extracellular matrix (5/CD49e and 1/CD29
integrins) clearly being displaced upon infection.
Comparison with microarray data. The Powerblot gener-
ated a data set comparable to that of a microarray, although
clearly pertaining to proteins rather than mRNA. A compari-
son of Powerblot and microarray data has the potential to
FIG. 3. Analysis of paxillin expression. (A) Densitometry readings from conventional Western blot assays and the Powerblot. Conventional
Western blotting data (MOI 
 5) are shown on the left for all three of the time points at which measurements were made (24, 72, and 144 hpi);
Powerblot data (MOI 
 5) were taken at a single time point (72 hpi) and are shown on the right. Only readings for the major 58-kDa band are
shown since only this band was present at levels high enough to give accurate readings. (B) Conventional Western blot assays from which the
densitometry readings were taken (MOI 
 5). (C) Immunofluorescence assay for paxillin performed at 72 hpi (MOI 
 5) with a strain AD169
variant or after mock infection.
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provide insight into the underlying control system regulating
cellular gene expression during productive HCMV infection.
Published microarray data on strain AD169-infected fibro-
blasts at 48 hpi (7) and 72 hpi (26) are available. Furthermore,
an Affymetrix microarray analysis was performed in our labo-
ratory with RNA harvested at 72 hpi with strain AD169,
thereby using conditions identical to those used in the Power-
blot (unpublished data). A direct comparison was made be-
tween confidence level 10 changes on Powerblot and the three
microarray studies. The exact n-fold change values were not
available for the Hertel and Mocarski data set. Some discrep-
ancies were observed in the microarray data that clearly could
be attributable to procedural differences (e.g., fibroblast type,
time point, strain AD169 variant, microarray technology). For
most of the confidence level 10 protein changes (Table 4), the
associated transcripts were found to be static upon HCMV
infection: 20/35 (57%) for Hertel and Mocarski, 34/51 (67%)
for Browne et al., and 40/49 (82%) for this report. Where a
change in steady-state RNA abundance was observed, the di-
rection of the change matched the Powerblot in 11/15 (73%)
cases for Hertel and Mocarski, 11/15 (73%) for Browne et al.,
and 5/9 (56%) for this report. Direct measurements of steady-
state RNA and protein levels are therefore not completely
compatible, implying a significant element of posttranscrip-
tional or posttranslational control of protein expression during
HCMV infection. The Hic-5 transcript decreased in abun-
dance in all three microarrays and by Powerblot, consistent
with a protein whose suppression did correlate well with RNA
abundance. In the microarray data sets, Eg-5 (three of three)
and RIG-G (two of two) were scored as no change whereas
FIG. 4. Analysis of Hic-5 expression. (A) Densitometry readings for Hic-5 levels in conventional Western blot assays (MOI 
 5) and the
Powerblot (MOI 
 5), with conventional Western blotting data on the left and those from the Powerblot on the right. Only levels of the major
58-kDa band are shown since the other bands were too weak to give meaningful measurements. (B) Conventional Western blot assays from which
densitometry measurements were taken (MOI 
 5). (C) Immunofluorescence assay for Hic-5 performed with HFFF infected 72 h previously with
strain AD169-GFP (MOI 
 5) or mock infected.
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protein expression was clearly increased, strongly suggesting
that the expression of these two proteins may be regulated at
the posttranscriptional level. There are also examples of pro-
teins which showed changes by microarray but not in the Pow-
erblot; for example, Pai-1 and tapasin gave good-quality bands
in the Powerblot and were unchanged upon HCMV infection
yet were significantly decreased in all three microarray data
sets.
DISCUSSION
Powerblot technology has been used to analyze the effect of
HCMV infection on the cellular proteome with more than
1,000 antibodies specific for known proteins. By using Western
blot technology, the system ensures that the reaction is against
a protein of the appropriate size and can generate data on
different isoforms of a single protein. In essence, the Powerblot
service is a proteomic screen analogous to a microarray in that
it tracks the expression of specific genes. By comparing protein
rather than mRNA levels, the readout has potentially greater
practical value to virologists. While the Powerblot samples an
impressive range of proteins, the technology is constrained to
a set collection of antibodies. In contrast, oligonucleotide mi-
croarrays have been expanded to permit sampling of steady-
state RNA levels for all human genes.
A conservative approach was taken in analyzing the Power-
blot data. Since the act of virus infection increases the total
amount of protein in the cells, attention was focused on pro-
teins exhibiting a greater-than-twofold difference in abun-
dance. By this criterion, most of the cellular proteome tested
remains relatively static during virus infection. Of the 694 pro-
teins that gave a positive signal, only 68 to 71 exhibited a level
10 confidence change in abundance in any one comparison,
with slightly more (57 to 63%) increasing than decreasing.
Although HCMV is associated with a general activation of
cellular gene expression, microarray data report that a minor-
ity (21%) of the cellular mRNAs sampled were modulated by
HCMV infection at 72 hpi and that the relative abundance of
more cellular RNAs was downregulated rather than upregu-
lated during HCMV infection (26). There are many reasons
why the modulation of cellular levels of mRNAs need not
necessarily translate into measurable changes in the absolute
amounts of their protein products. The relative stability of any
particular protein is important in this analysis. The synthesis of
a protein may be either suppressed or enhanced but not result
in an appreciable change in steady-state levels during the
course of even a slow virus infection.
The direct comparison between strain AD169-infected and
strain Toledo-infected cells identified only 13 proteins changed
with the highest confidence (level 10) when cells infected with
the two viruses were compared with each other (see Fig. SD in
the supplemental material). The magnitudes of Eg-5 and
RIG-G activation observed in the more detailed follow-up
investigation were both greater with the laboratory-adapted
virus. However, despite the reported differences in pathogen-
esis and genetic makeup of strains AD169 and Toledo, the
differential effect on the host proteome was relatively modest.
We intend to investigate this aspect further by using both
Powerblot and specific antibodies to identify consistent
changes attributable to specific gene functions that could be
linked with virulence. In this context, the UL/b-encoded NK
evasion function UL141 has been shown to retain the activat-
ing ligand CD155 in the endoplasmic reticulum as an immature
low-molecular-weight precursor. If an antibody specific for
CD155 had been included in the array, the retention of CD155
by gpUL141 should have been apparent in the Powerblot anal-
ysis. Overall, the Powerblot has proved more instructive than
the gene array with respect to strain differences; in the fol-
low-up of a DNA microarray analysis in which 58 cellular genes
were analyzed by Northern blotting, all exhibited similar reg-
ulation by both HCMV strains AD169 and Toledo (66).
The reliability of the Powerblot data was tested in a fol-
low-up study that used antibodies specific for proteins identi-
fied as being modulated by HCMV infection. Visual inspection
of the original Powerblot data (available on request) supported
the BD computer-aided analyses (see Fig. SB to SD in the
supplemental material) of these proteins over the triplicate
samples. However, three of the nine proteins initially analyzed
exhibited no obvious change in abundance in a conventional
Western blot analysis. Although cell extracts were prepared by
the same method, some variation in the biological sample is
inevitable. The Powerblot requires large protein samples (4
mg) and is relatively expensive; thus, the system is less ame-
nable to the running of multiple independent biological sam-
ples than is microarray technology. The false result obtained
with the ZAG antibody also illustrated that the probing of
single samples with multiple antibodies to differentially migrat-
ing proteins can lead to misinterpretation and reinforces the
need to validate the results for specific proteins independently.
Nevertheless, for six of the nine proteins we analyzed we were
able to validate the Powerblot data. Thus, the Powerblot has
generated a large data set for a wide range of cellular proteins
that we show here can be usefully tested.
The efficient downregulation of connexin 43 can be expected
to have a major impact on intercellular communications in-
FIG. 5. Immunofluorescence assays performed 72 hpi with strain
AD169-GFP (MOI 
 5) or after mock infection for focal-adhesion
components FAK, -actinin, CD49e (integrin 5), and CD29 (in-
tegrin 1).
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TABLE 4. Transcript level changes upon HCMV (AD169) infection taken from
microarray data for proteins showing level 10 changes in Powerblota
a NC, no change (medium grey shading); D, decrease (black shading); MD, moderate decrease
(black shading); I, increase (light grey shading); MI, moderate increase (light grey shading); /0,
protein increased from undetectable; /0, protein downmodulated to become undetectable.
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volving HCMV-infected cells. Connexin 43 is the predominant
connexin expressed in fibroblasts, and it will be interesting to
investigate the effect of HCMV infection on additional con-
nexins in cells other than fibroblasts. It will also be important
to investigate whether active infection is capable of disrupting
established gap junctions. The disassembly of connexin pores
could either be a cellular defense to limit virus dissemination
or be required by HCMV to prevent the induction of an anti-
viral state in neighboring cells. The human papillomavirus 16
E5 protein has also been shown to downregulate connexin 43
(41, 52), and thus in this case the disassembly of gap junctions
appears to be a viral virulence function rather than a host
defense.
HCMV was revealed to have a major effect on proteins
associated with the formation of focal adhesions; -actinin,
paxillin, and Hic-5 were all downregulated and, along with
FAK, physically dispersed from structures associated with focal
adhesions. Depolymerization of actin filaments has long been
associated with virion entry and the early phase of infection
(30, 37, 59); thus, the breakdown of -actinin filaments is
consistent. The disruption of stress fibers may be anticipated to
have an impact on the integrity of adhesion junctions, and the
events may be causally linked. Many focal-adhesion proteins
have been implicated in the regulation of actin filament reor-
ganization (8, 29, 33, 55), potentially linking the effect with the
CPE induced upon CMV infection. In this context, FAK, fil-
amin, and p-190-B were all identified by Powerblot as being
suppressed by HCMV infection. Eg5 was selected for fol-
low-up because its expression was enhanced. Although Eg5
expression is reduced when a cell is not actively dividing, it also
increases when changes in cellular architecture are occurring
(18). This is especially interesting given that Eg5 levels are
affected differently in strains AD169 and Toledo, as the CPEs
induced by these viruses are known to be distinct (32).
While HCMV suppresses the transcription and expression
of components of the extracellular matrix in productive infec-
tion, preexisting components appear to persist (28, 47). The
Powerblot detects high levels of fibronectin in infected cells,
consistent with the extracellular matrix surviving infection. In-
tegrins play a key role in anchoring focal adhesions, directly
linking the cytoskeleton with the extracellular matrix. Gener-
ally, integrin subunits (5/CD51, 2/CD49b, 3/CD49c, 5,
LFA-1, 4, ICAM-1) generated weak signals in the Powerblot
that were not obviously modulated in response to infection.
Integrin subunits 1 and 4 were the exception, being identi-
fied as being reduced with level 10 and level 9 confidence,
respectively, in infected cells. The indication that HCMV
downregulates a subset of integrin subunits is consistent with
the previously published observation that the virus selectively
downregulates 1/1 integrin (60). Direct examination of the
expression of both 5 and 1 integrins by immunofluorescence
clearly demonstrated that both were displaced from character-
istic focal adhesions during infection.
There was limited concordance between steady-state RNA
levels detected by microarray analysis and protein expression
detected by Powerblot and follow-up studies. A degree of
experimental variation can be expected when comparing RNA
microarray or Powerblot studies performed at different times
and in different laboratories. Nevertheless, generally, changes
in protein expression did not correlate well with RNA abun-
dance, suggesting that the primary mechanism for controlling
the abundance of cellular proteins during HCMV infection
may not be at the transcriptional level. It was most interesting
to see the virus targeting the expression of focal-adhesion
proteins as a group, thus presumably disabling all of the asso-
ciated key cellular functions in cell migration and adhesion
associated with these structures. We speculate that once these
structures have been disrupted, their component proteins
may become vulnerable to proteolysis. Thus, a group of
proteins may potentially be controlled en bloc on the post-
translational level. Powerblot has defined a substantial set of
host cell genes whose expression is modulated during
HCMV infection that were not identified by microarray
technology. Clearly, the mechanisms responsible for virus
control cellular need to be further elaborated. Through the
systematic application of HCMV deletion mutants, it may
prove possible to identify the HCMV genes responsible for
controlling their expression.
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